< Back to latest news & events

Event

IQPC Life Science IP 2019 – London

November 2019

Event date: 26th November 2019

HGF are sponsoring IQPC Life Science IP conference on 26-27 November in London with Partner Martyn Fish, Legal Director Michelle Davies and Partner Rachel Fetches attending.

Life Science IP 2019 will include a range of subjects around practical strategies for navigating the regulatory landscape and maximising the value of IP within Life Science, whilst sharing practical knowledge with speakers and colleagues.

Martyn Fish will be chairing day 1 and will be joining a panel debate ‘Alternative Means of IP Protection’.

He will be discussing ‘What alternative forms of protection to patent protection exist for the pharmaceutical industry: Can gene sequences be protected by copyright? Developments in the drug names? Design Right in chemical structures?’

  • Trade secrets
  • Trade marks – GSK’s Seretide inhaler
  • Copyright
  • Designs – claiming infringement for the copy of medicine designs.

Michelle Davies will be presenting on day 1 ‘Legal Risk Mitigation & Minimisation Across your Business’:

Issues across the business are inevitable, from the inadvertent disclosure of sensitive information through to adverse event reporting, patient interactions, manufacturing problems or product recall. Whilst some risks can be avoided, it is often the inappropriate handling of situations and panic responses made by a business that can cause the greatest damage.

Steps can be taken as a matter of good business practice to prevent or minimise business risk and exposure. With twelve years’ experience supporting business teams and functions within the pharmaceutical industry, Michelle will discuss her insights and the practical steps she deems most effective.

Latest updates

Can AI replace patent attorneys?

OpenAI recently released a dialogue-based AI chatbot called ChatGPT, which is free for anyone to try out. You can try it here (https://chat.openai.com/chat). It’s been shown that it can set, …

Read article

HGF office closures in December 2022 and January 2023

Please note that our offices will be closed for business in accordance with national holidays on the following dates. Please plan accordingly and provide us with your instructions in advance …

Read article

Start of the UPC Sunrise Period delayed to 1 March 2023

The UPC sunrise period which was expected to start on 1 January 2023 has now been postponed to 1 March 2023. Consequently, the entry into force of the UPCA and …

Read article

Gender diversity at the UPC

In Europe, women remain grossly under-represented in research and innovation. A recent study by the European Patent Office (EPO) found that only 13.2% of inventors in Europe are women. The …

Read article
Event - 29th November 2022

LSPN Europe 2022

HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …

Event details

Oral Proceedings by videoconference (VICO) in oppositions proceedings to become permanent

The pilot project for oral proceedings in opposition proceedings by video conference (VICO) started during the pandemic and has received positive feedback.[1] The President of the EPO has therefore declared …

Read article